RUNX2 and cleidocranial dysplasia 1: The effect was of greater magnitude using a truncated mouse osteocalcin promoter, p147, where 16Q and 30Q variant activity overlapped that of some RUNX2 mutations that are associated with cleidocranial dysplasia.